Siemens Healthineers AG

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 16:38:06 23/01/2026 GMT			5-day change	1st Jan Change
43.30 ^EUR	-1.84%		-6.48%	-3.61%

01-23	SIEMENS HEALTHINEERS : Receives a Buy rating from Berenberg	ZD
01-22	SIEMENS HEALTHINEERS : UBS reiterates its Neutral rating	ZD

SIEMENS HEALTHINEERS : Receives a Buy rating from Barclays

Published on 11/24/2025 at 12:24 pm GMT

MarketScreener with dpa-AFX Analyser

SIEMENS HEALTHINEERS AG

-1.84%

In his latest research note, analyst Hassan Al-Wakeel confirms his positive recommendation. The broker Barclays is keeping its Buy rating. The target price is set at 61.50 versus 61.00 EUR.

Latest news about Siemens Healthineers AG

01-23	SIEMENS HEALTHINEERS : Receives a Buy rating from Berenberg	ZD
01-22	SIEMENS HEALTHINEERS : UBS reiterates its Neutral rating	ZD
01-20	EARNINGS AND TRADING: Treatt cuts dividend after "challenging year"	AN
01-20	Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management	CI
01-16	SIEMENS HEALTHINEERS : RBC remains its Buy rating	ZD
01-15	SIEMENS HEALTHINEERS : UBS reiterates its Neutral rating	ZD
01-15	UBS Raises Price Target for Siemens Healthineers to 51 Euros – 'Neutral'	DP
01-15	SIEMENS HEALTHINEERS : JP Morgan remains its Buy rating	ZD
01-14	Siemens Healthineers AG Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:00 PM
01-14	BofA Maintains Siemens Healthineers Buy Rating Ahead of Fiscal Q1 Results	MT
01-13	Siemens Healthineers Seeks Tuck-In Acquisitions	CI
01-13	SIEMENS HEALTHINEERS : Bernstein remains its Buy rating	ZD
01-06	SIEMENS HEALTHINEERS : Gets a Neutral rating from Deutsche Bank	ZD
01-06	BofA Sees Margin Expansion for Siemens AG in FY26 Amid Continued Recovery	MT
01-02	Dax and MDax: Fewer Women on Executive Boards	DP
12-19	SIEMENS HEALTHINEERS : Receives a Buy rating from Jefferies	ZD
12-18	Raysearch Recruits Jenna Styan as Chief Strategy Officer	FW
12-18	SIEMENS HEALTHINEERS : Barclays remains its Buy rating	ZD
12-18	Barclays Lowers Target Price for Siemens Healthineers to 61 Euros - 'OW'	DP
12-18	RBC Begins Siemens Healthineers at Outperform on 'Leading' Market Position, Earnings Growth Potential	MT
12-17	German DAX Index Down as Eurozone Inflation Holds Steady	MT
12-17	Bernstein Restarts Siemens Healthineers Coverage at Outperform, Says Headwinds Already Priced In	MT
12-17	SIEMENS HEALTHINEERS : Receives a Buy rating from RBC	ZD
12-17	RBC initiates coverage of Siemens Healthineers with "Outperform" rating and €55 target price	DP
12-16	SIEMENS HEALTHINEERS : Receives a Buy rating from Bernstein	ZD

Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (54.6%); - sale of diagnostic equipment (18.7%); - sale of solutions and services for cancer care (17.6%); - sale of advanced therapeutic solutions (9.1%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (5.1%), Europe/ CIS/Africa/Middle East (28.2%), the United States (35.9%), America (6.2%), China (11.4%) and Asia/Pacific and Japan (13.2%).

Employees

72,369

Sector

Advanced Medical Equipment & Technology

Calendar

02-05 - Q1 2026 Earnings Release

More about the company